@article{d600b093a8a543f594f6b872b365193f,
title = "An open-label cluster-randomized controlled trial of chloroquine, hydroxychloroquine or only supportive care in patients admitted with moderate to severe COVID-19 (ARCHAIC)-Protocol publication",
keywords = "Antiviral Agents/therapeutic use, Betacoronavirus, COVID-19, Chloroquine/therapeutic use, Coronavirus Infections/drug therapy, Electrocardiography, Hospitalization, Humans, Hydroxychloroquine/therapeutic use, Long QT Syndrome/chemically induced, Netherlands, Pandemics, Pneumonia, Viral/drug therapy, SARS-CoV-2, Severity of Illness Index, Treatment Outcome",
author = "Weehuizen, \{Jesper M\} and Hoepelman, \{Andy I M\}",
note = "Funding Information: The sponsor of this study is ZonMw; Netherlands organization for Health Research and Development. The study did not received any (financial) support from the pharmaceutical industry. There are no financial conflicts of interest to disclose. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.",
year = "2020",
month = jul,
doi = "10.1111/eci.13297",
language = "English",
volume = "50",
journal = "European Journal of Clinical Investigation",
issn = "0014-2972",
publisher = "John Wiley \& Sons Inc.",
number = "7",
}